Novel fluorescence assay using calcein-AM for the determination of human erythrocyte viability and aging

Cytometry Part A

Volumn 66, Issue 1, 2005, Pages 78-84

  Bratosin, Daniela ^a,e   Mitrofan, Laura ^b   Palii, Carmen ^c   Estaquier, Jérôme ^d   Montreuil, Jean ^e  

^a Institut National de Recherche et Developpement Pour les Textiles Bucharest   (Romania)

^b INSTITUTE OF BIOLOGY   (Romania)

^c ALEXANDRU IOAN CUZA UNIVERSITY OF IASI   (Romania)

^d INSTITUT PASTEUR   (France)

^e UNIV LILLE   (France)

Author keywords

Aging; Blood storage; Calcein AM; Cell death; Flow cytometry; Red blood cell; Viability

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCEIN; CALCIUM ION; ESTERASE; GREEN FLUORESCENT PROTEIN; LIPOCORTIN 5; PHOSPHATIDYLSERINE; PHYCOERYTHRIN;

APOPTOSIS; ARTICLE; CELL AGING; CELL LABELING; CELL MEMBRANE; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SPECTROFLUOROMETRY; STAINING; ULTRACENTRIFUGATION;

EID: 20944442355     PISSN: 15524922     EISSN: None     Source Type: Journal    
DOI: 10.1002/cyto.a.20152     Document Type: Article

References (40)

1. Bruning JW, Kardol M, Arentzen R. Carboxyfluorescein fluorochromasia assay. I. Non-radioactively labeled cell mediated lympholysis. J Immunol Methods 1980;33:33-44.
2. Haugland RE Handbook of fluorescent probes and research products. Eugene, OR: Molecular Probes; 2002.
3. Western SA, Parish CR. New fluorescent dyes for lymphocyte migration studies. Analysis by flow cytometry and fluorescence microscopy. J Immunol Methods 1990;133:87-97.
4. Homolya L, Hollo Z, Germann UA, Pastan I, Gottesman MM, Sarkadi B. Fluorescent cellular indicators are extruded by the multidrug resistance protein. J Biol Chem 1993;268:21493-21496.
5. Hollo Z, Homolya L, Hegedus T, Sarkadi B. Transport properties of the multidrug resistance-associated protein (MRP) in human tumour cell. FEBS Lett 1996;383:99-104.
6. Bell RS, Bouret LA, Bell DF, Gebhardt MC, Rosenberg A, Berrey HB, Treadwell BV, Tomford WW, Mankin HJ. Evaluation of fluorescein diacetate for flow cytometric determination of cell viability in orthopaedic research. J Orthop Res 1988;6:467-474.
7. Ross DD, Joneckis CC, Ordonez JV, Sisk AM, Wu RK, Hamburger AW, Nora RE. Estimation of cell survival by flow cytometric quantification of fluorescein diacetate/propidium iodide viable cell number. Cancer Res 1989;49:3776-3782.
8. Levesque A, Paquet A, Page M. Measurement of tumor necrosis factor activity by flow cytometry. Cytometry 1995;20:181-184.
9. Noel-Hudson MS, Braut-Boucher F, Robert M, Aubery M, Wepierre J. Comparison of six different methods to assess UVA cytotoxicity on reconstructed epidermis. Relevance of a fluorometric assay (the calcein-AM) to evaluate the photoprotective effect of tocopherol. Toxicol In Vitro 1997;11:645-651.
10. Kapanen A, Danilov A, Lehenkari P, Ryhanen J, Jämsä T, Tuukkanen J. Effect of metal alloy surface stresses on the viability of ROS-17/2.8 osteoblastic cells. Biomaterials 2002;23:3733-3740.
11. Chen CC, Chang JH, Lee JB, Javier J, Azar DT. Human corneal epithelial cell viability and morphology after dilute alcohol exposure. Invest Ophthalmol Vis Sci 2002;43:2593-2602.
12. Kaya T, Torisawa Y, Oyamatsu D, Nishizawa M, Matsue T. Monitoring the cellular activity of a cultured single cell by scanning electrochemical microscopy (SECM). A comparison with fluorescence viability monitoring. Biosens Bioelectron 2003;18:1379-1383.
13. Callewaert DM, Radcliff G, Waite R, LeFevre J, Poulik MD. Characterization of effector-target conjugates for cloned human natural killer and human lymphokine activated killer cells by flow cytometry. Cytometry 1991;12:666-676.
14. Wang XM, Terasaki PI, Rankin GW Jr, Chia D, Zhong HP, Hardy S. A new microcellular cytotoxicity test based on calcein AM release. Hum Immunol 1993;37:264-270.
15. Papadopoulos NG, Dedoussis GVZ, Spanakos G, Gritzapis AD, Baxevanis CN, Papamichail M. An improved fluorescence assay for the determination of lymphocyte-mediated cytotoxicity using flow cytometry. J Immunol Methods 1994;177:101-111.
16. Lichtenfels R, Biddison WE, Schulz H, Vogt AB, Martin R. CARE-LASS (calcein-release-assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity. J Immunol Methods 1994; 172:227-239.
17. Roden MM, Lee KH, Panelli MC, Marincola FM. A novel cytolysis assay using fluorescent labeling and quantitative fluorescent scanning technology. J Immunol Methods 1999;226:29-41.
18. Neri S, Mariani E, Meneghetti A, Cattini L, Facchini A. Calcein-acetoxymethyl cytotoxicity assays: standardization of a method allowing additional analyses on recovered effector cells and supernatants. Clin Diagn Lab Immunol 2001;8:1131-1135.
19. Estaquier J, Tanaka M, Suda T, Nagata S, Golstein P, Ameisen JC. Fas-mediated apoptosis of CD4+ and CD8+ T cells from human immunodeficiency virus-infected persons: differential in vitro preventive effect of cytokines and protease antagonists. Blood 1996;87:4959-4966.
20. Gatti R, Belletti S, Orlandini G, Bussolati O, Dall'Asta V, Gazzola GC. Comparison of annexin V and calcein-AM as early vital markers of apoptosis in adherent cells by confocal laser microscopy. J Histochem Cytochem 1998;46:895-900.
21. King MA. Detection of dead cells and measurement of cell killing by flow cytometry. J Immunol Methods 2000;243:155-166.
22. Ben Jilani KE, Akarid K, Arnoult D, Petit F, Baert E, Gaillard JP, Ameisen JC, Estaquier J. Gamma-interferon induces apoptosis of the B lymphoma WEHI-279 cell line through a CD95/CD95L-independent mechanism. Eur Cytokine Netw 2001;12:587-596.
23. Green PS, Leeuwenburgh C. Mitochondrial dysfunction is an early indicator of doxorubicin-induced apoptosis. Biochim Biophys Acta 2002;1588:94-101.
24. Gylys KH, Fein JA, Wiley DJ, Cole GM. Rapid annexin-V labeling in synaptosomes. Neurochem Int 2004;44:125-131.
25. Pulaski L, Jedlitschky G, Leier I, Buchrolz U, Keppler D. Identification of the multidrug resistance protein (MRP) as the glutathione-S-conjugate export pump of erythrocytes. Eur J Biochem 1996;241:644-648.
26. Bobrowska-Hägerstrand M, Wróbel A, Rychlick B, Bartosz G, Söderström T, Shirataki Y, Motohashi N, Molnár J. Michalak K, Hägerstrand H. Monitoring of MRP-like activity in human erythrocytes: inhibitory effect of isoflavones. Blood Cells Mol Dis 2001;27: 894-900.
27. Rychlik B, Balcerczzyk A, Bartosz G. The role of multidrug resistance protein 1 (MRP1) in transport of fluorescent anion across the human erythrocyte membrane. J Membr Biol 2003;193:79-90.
28. Bratosin D, Estaquier J, Petit F, Arnoult D, Quatannens B, Tissier JP, Slomianny C, Sartiaux C, Alonso C. Huart JJ, Montreuil J, Ameisen JC. Programmed cell death in mature erythrocytes: a model for investigating death effector pathways operating in the absence of mitochondria. Cell Death Differ 2001;8:1143-1156.
29. Berg CP, Engels IH, Rothbart A, Lauber K, Renz A, Schlosser SF, Schulze-Osthoff K, Wesselborg S. Human mature red blood cells express caspase-3 and caspase-8, but are devoid of mitochondrial regulators of apoptosis. Cell Death Differ 2001;8:1197-1206.
30. Bratosin D, Estaquier J, Ameisen JC, Montreuil J. Molecular and cellular mechanisms of erythrocyte programmed cell death: impact on blood transfusion. Vox Sang 2002;83(suppl 1)307-310.
31. Lutz HU, Stammler P, Fasler S, Ingold M, Fehr J. Density separation of human red blood cells on self-forming Percoll gradients: correlation with cell age. Biochim Biophys Acta 1992;1116:1-10.
32. Bratosin D, Mazurier J, Debray H, Lecocq M, Boilly B, Alonso C, Moisei M, Motas C, Montreuil J. Flow cytofluorimetric analysis of young and senescent human erythrocytes probed with lectins. Evidence that sialic acids control their life span. Glycoconj J 1995;12:258-267.
33. Jacob BC, Favre M, Bensa JC. Membrane cell permeabilisation with saponin and multiparametric analysis by flow cytometry. Cytometry 1991;12:550-558.
34. Prall YG, Gambhir KK, Ampy FR. Acetylcholinesterase: an enzymatic marker of human red blood cell aging. Life Sci 1998;63:177-184.
35. Bratosin D, Mazurier J, Tissier JP, Slomianny C, Estaquier J, Russo-Marie F, Huart JJ, Freyssinet JM, Aminoff D, Ameisen JC, Montreuil J. Molecular mechanisms of erythrophagocytosis. Characterization of the senescent erythrocytes that are phagocytized by macrophages. C R Acad Sci 1997;320:811-818.
36. Zwaal RF, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997;89:1121-1132.
37. Boas FE, Forman L, Beutler E. Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia. Proc Natl Acad Sci USA. 1998;95:3077-3081.
38. Sorette MP, Galili U, Clark MR. Comparison of serum anti-band 3 and anti-Gal antibody binding to density-separated human red blood cells. Blood 1991;77:628-636.
39. Bratosin D, Estaquier J, Slomianny C, Tissier JP, Quatannens B, Bulai T, Mitrofan L, Marinescu A, Trandaburu I, Ameisen JC, Montreuil J. On the evolution of erythrocyte programmed cell death: apoptosis of Rana esculenta nucleated red blood cells involves cysteine proteinase activation and mitochondrion permeabilization. Biochimie 2004;86: 183-192.
40. Beutler E. Back to the future in RBC preservation. Transfusion 2000; 40:893-895.